FdaApplication
ANDA 203217
Identifiers
- fda_app_no: ANDA203217
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2015-05-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE;ORAL |
1 product